Furthermore, the rate of rebound weight gain following the cessation of GLP-1R agonists, as well as the implementation of future strategies to avoid this phenomenon, are other issues that need to be thoroughly addressed in future studies [65]
Moreover, even though our strategies have evolved and can now result in type 2 diabetes remission, many people are not accessing diabetes prevention, control or remission, which should be the cornerstone of the therapeutic approach
The effects of GLP-1 analogues on pre-diabetes of the children
For most patients, gastrointestinal symptoms settle down within a few weeks
During the weight loss phase changes in food selection, reduction in appetite, and changes in gastrointestinal hormone levels are known to play a significant role [3]